Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von SpringheelJack 

Microbot Medical Inc diskutieren

Microbot Medical Inc

WKN: A2N5AS / Symbol: STEM / Name: Microbot Medical / Aktie / Micro Cap /

0,88 €
1,32 %

Buy Microbot Medical Inc

Einschätzung Buy
Rendite (%) -37,27 %
Kursziel 11,01
Veränderung
Endet am 03.04.24

Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at Morgan Stanley from $15.00 to $12.00. They now have an "overweight" rating on the stock.
Ratings data for STEM provided by MarketBeat

Einschätzung Sell
Rendite (%) -37,65 %
Kursziel 4,59
Veränderung
Endet am 04.04.24

Stem, Inc. (NYSE: STEM) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $5.00 price target on the stock, down previously from $9.00.
Ratings data for STEM provided by MarketBeat

Einschätzung Buy
Rendite (%) -12,00 %
Kursziel 7,29
Veränderung
Endet am 05.05.24

Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at TD Cowen from $11.00 to $8.00. They now have an "outperform" rating on the stock.
Ratings data for STEM provided by MarketBeat

Stem, Inc. (NYSE: STEM) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
Ratings data for STEM provided by MarketBeat

Einschätzung Buy
Rendite (%) -56,50 %
Kursziel 11,24
Veränderung
Endet am 06.06.24

Stem, Inc. (NYSE: STEM) is now covered by analysts at Janney Montgomery Scott. They set a "buy" rating and a $12.00 price target on the stock.
Ratings data for STEM provided by MarketBeat

Einschätzung Buy
Rendite (%) -24,79 %
Kursziel 5,51
Veränderung
Endet am 24.01.25

Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $7.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for STEM provided by MarketBeat

Einschätzung Buy
Rendite (%) -32,80 %
Kursziel 3,69
Veränderung
Endet am 28.02.25

Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at Susquehanna from $5.50 to $4.00. They now have a "positive" rating on the stock.
Ratings data for STEM provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 8,36
Veränderung
Endet am 03.05.25

Stem, Inc. (NYSE: STEM) had its price target lowered by analysts at Evercore ISI from $13.00 to $9.00. They now have an "outperform" rating on the stock.
Ratings data for STEM provided by MarketBeat